CSIMarket Company Name, Ticker, Industry, else..


Vir Biotechnology Inc   (NASDAQ: VIR)
Other Ticker:  
 

Vir Biotechnology Inc

VIR's Fundamental analysis



Vir Biotechnology Inc 's sales fell by -9.81 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 2907

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.31 %

Vir Biotechnology Inc net loss increased from $-163 millions, to $-214 millions in III. Quarter 2024,

• More on VIR's Growth


Vir Biotechnology Inc
realized a net loss in trailing twelve months.

Vir Biotechnology Inc realized cash reduction of $ -1.52 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 18.48.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.57.


• More on VIR's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 538,479
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 8.81

Vir Biotechnology Inc
realized net loss in trailing twelve months.

Vir Biotechnology Inc realized cash outflow of $ -1.52per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 18.48.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.57.

Vir Biotechnology Inc Price to Book Ratio is at 1.17 lower than Industry Avg. of 476.88. and higher than S&P 500 Avg. of 0.01

• More on VIR's Valuation

•  Market Capitalization (Millions $) 1,453
•  Shares Outstanding (Millions) 137
•  Employees 146
•  Revenues (TTM) (Millions $) 79
•  Net Income (TTM) (Millions $) -533
•  Cash Flow (TTM) (Millions $) -208
•  Capital Exp. (TTM) (Millions $) -6
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 538,479
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 8.81

•  Market Capitalization (Millions $) 1,453
•  Shares Outstanding (Millions) 137
•  Employees 146
•  Revenues (TTM) (Millions $) 79
•  Net Income (TTM) (Millions $) -533
•  Cash Flow (TTM) (Millions $) -208
•  Capital Exp. (TTM) (Millions $) -6





  Ratio
•   Capital Ratio (MRQ) 8.94
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.21
•  Asset Turnover Ratio (TTM) 0.05
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com